FR2828487B1 - Nouveaux composes derives d'acides gras, preparation et utilisations - Google Patents

Nouveaux composes derives d'acides gras, preparation et utilisations

Info

Publication number
FR2828487B1
FR2828487B1 FR0110645A FR0110645A FR2828487B1 FR 2828487 B1 FR2828487 B1 FR 2828487B1 FR 0110645 A FR0110645 A FR 0110645A FR 0110645 A FR0110645 A FR 0110645A FR 2828487 B1 FR2828487 B1 FR 2828487B1
Authority
FR
France
Prior art keywords
preparation
fatty acids
novel compounds
compounds derived
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0110645A
Other languages
English (en)
French (fr)
Other versions
FR2828487A1 (fr
Inventor
Fruchart Jamila Najib
Bertrand Karine Caumont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0110645A priority Critical patent/FR2828487B1/fr
Application filed by Genfit SA filed Critical Genfit SA
Priority to ES02779622T priority patent/ES2292824T3/es
Priority to DK02779622T priority patent/DK1673338T3/da
Priority to JP2003519023A priority patent/JP2004537595A/ja
Priority to AU2002342968A priority patent/AU2002342968B2/en
Priority to CA002456288A priority patent/CA2456288A1/fr
Priority to AT02779622T priority patent/ATE373638T1/de
Priority to US10/484,350 priority patent/US7375135B2/en
Priority to PCT/FR2002/002831 priority patent/WO2003014073A1/fr
Priority to PT02779622T priority patent/PT1673338E/pt
Priority to SI200230624T priority patent/SI1673338T1/sl
Priority to DE60222596T priority patent/DE60222596T2/de
Priority to EP02779622A priority patent/EP1673338B1/fr
Publication of FR2828487A1 publication Critical patent/FR2828487A1/fr
Application granted granted Critical
Publication of FR2828487B1 publication Critical patent/FR2828487B1/fr
Priority to CY20071101482T priority patent/CY1107806T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
FR0110645A 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations Expired - Fee Related FR2828487B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0110645A FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations
SI200230624T SI1673338T1 (sl) 2001-08-09 2002-08-08 Spojine maščobne kisline, priprava in njihova uporaba
JP2003519023A JP2004537595A (ja) 2001-08-09 2002-08-08 脂肪酸誘導体、その製造法及び使用
AU2002342968A AU2002342968B2 (en) 2001-08-09 2002-08-08 Fatty acid compounds, preparation and uses thereof
CA002456288A CA2456288A1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
AT02779622T ATE373638T1 (de) 2001-08-09 2002-08-08 Fettsäureverbindungen und deren herstellung und verwendungen
US10/484,350 US7375135B2 (en) 2001-08-09 2002-08-08 Fatty acid derivatives; preparation and uses thereof
PCT/FR2002/002831 WO2003014073A1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
ES02779622T ES2292824T3 (es) 2001-08-09 2002-08-08 Compuestos derivados de acidos grasos, preparacion y utilizaciones.
DK02779622T DK1673338T3 (da) 2001-08-09 2002-08-08 Forbindelser afledt af fedtsyrer, fremstilling og anvendelse
DE60222596T DE60222596T2 (de) 2001-08-09 2002-08-08 Fettsäureverbindungen und deren herstellung und verwendungen
EP02779622A EP1673338B1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
PT02779622T PT1673338E (pt) 2001-08-09 2002-08-08 Compostos derivados de ácidos gordos, preparação e utilizações
CY20071101482T CY1107806T1 (el) 2001-08-09 2007-11-16 Ενωσεις παραγωγα λιπαρων οξεων, παρασκευη και χρησεις τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0110645A FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations

Publications (2)

Publication Number Publication Date
FR2828487A1 FR2828487A1 (fr) 2003-02-14
FR2828487B1 true FR2828487B1 (fr) 2005-05-27

Family

ID=8866413

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0110645A Expired - Fee Related FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations

Country Status (13)

Country Link
US (1) US7375135B2 (OSRAM)
EP (1) EP1673338B1 (OSRAM)
JP (1) JP2004537595A (OSRAM)
AT (1) ATE373638T1 (OSRAM)
AU (1) AU2002342968B2 (OSRAM)
CA (1) CA2456288A1 (OSRAM)
CY (1) CY1107806T1 (OSRAM)
DE (1) DE60222596T2 (OSRAM)
DK (1) DK1673338T3 (OSRAM)
ES (1) ES2292824T3 (OSRAM)
FR (1) FR2828487B1 (OSRAM)
PT (1) PT1673338E (OSRAM)
WO (1) WO2003014073A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850870B1 (fr) * 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
FR2853834B1 (fr) * 2003-04-17 2008-08-15 Vincience Composition cosmetique ou pharmaceutique comprenant l'association d'au moins un diacyglycerol et d'au moins un alcool gras
FR2858216B1 (fr) * 2003-07-31 2008-04-04 Oreal Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
RU2388490C2 (ru) * 2004-07-19 2010-05-10 Тиа Медика Ас Композиция, содержащая растительный или рыбий жир, и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
KR20070054637A (ko) * 2004-07-19 2007-05-29 티아 메디카 에이에스 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
DE102007051338A1 (de) * 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
JP5620272B2 (ja) 2007-11-09 2014-11-05 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ ＮｏｒｇｅＡＳ 化粧品において，食品サプリメントとして，または医薬品として用いるための脂質化合物
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
EP2427415B1 (en) 2009-05-08 2019-03-20 Basf As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
EP2445494A4 (en) * 2009-06-24 2012-12-12 Univ Koebenhavn TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
AU2011324909B2 (en) 2010-11-05 2016-09-08 Pronova Biopharma Norge As Methods of treatment using lipid compounds
EP3578170A1 (en) 2013-02-28 2019-12-11 Basf As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
CA3052449C (en) 2013-03-11 2021-10-19 Jan Remmereit Lipid compositions comprising 5, 11, 14-eicosatrienoic acid and conjugated linoleic acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
CN115025079A (zh) 2015-04-28 2022-09-09 普罗诺瓦生物医药挪威公司 结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途
JP7157531B2 (ja) 2015-05-20 2022-10-20 アピール テクノロジー，インコーポレイテッド 植物抽出物組成物およびその調製方法
WO2017048951A1 (en) 2015-09-16 2017-03-23 Apeel Technology, Inc. Precursor compounds for molecular coatings
FR3044556B1 (fr) 2015-12-08 2019-10-18 Pierre Fabre Dermo-Cosmetique Utilisation de diglyceride 1,3 dans une composition topique pour lutter contre la fragilisation de la barriere cutanee
JP6549326B2 (ja) 2015-12-10 2019-07-24 アピール テクノロジー，インコーポレイテッド 保護コーティングを形成するための植物抽出物組成物
EP3407713A1 (en) 2016-01-26 2018-12-05 Apeel Technology, Inc. Method for preparing and preserving sanitized products
EP3541192B1 (en) 2016-11-17 2025-06-25 Apeel Technology, Inc. Methods of preparing fatty acid esters from crosslinked polyesters
EP3661600A4 (en) 2017-10-23 2021-08-11 Epitracker, Inc. FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
CA3084728A1 (en) 2017-12-06 2019-06-13 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
WO2019222254A1 (en) * 2018-05-16 2019-11-21 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to aging
JP2021525249A (ja) 2018-05-23 2021-09-24 エピトラッカー インコーポレイテッドＥｐｉｔｒａｃｋｅｒ， Ｉｎｃ． 加齢及び長期性の質に関連する状態の診断及び治療のための組成物及び方法
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
WO2020146263A1 (en) 2019-01-09 2020-07-16 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
CN115443066A (zh) 2020-03-04 2022-12-06 阿比尔技术公司 涂覆的农业产品和相应的方法
JP2023548012A (ja) 2020-10-30 2023-11-15 アピール テクノロジー，インコーポレイテッド 組成物及びその調製方法
JP2024532457A (ja) 2021-09-08 2024-09-05 アピール テクノロジー，インコーポレイテッド 保護コーティング用の化合物及び配合物
EP4426130A1 (en) 2021-11-03 2024-09-11 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
US12133863B1 (en) * 2023-06-07 2024-11-05 King Saud University Green synthesis of silver nanoparticles encapsulated in a nanostructured lipid carrier

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010154A (en) * 1933-06-27 1935-08-06 Herbert S Kreighbaum Ether acid ester of polyhydric alcohols
GB1271179A (en) * 1969-06-11 1972-04-19 Mitsubishi Petrochemical Co Polyolefin resin composition
JPS5738616B2 (OSRAM) * 1974-06-19 1982-08-17
US4134770A (en) * 1976-09-22 1979-01-16 Mitsubishi Paper Mills, Ltd. Gelatin-containing photographic layer incorporated with hardener
IL59407A (en) * 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
JPS5782573A (en) * 1980-11-05 1982-05-24 Matsumoto Yushi Seiyaku Kk Smoothening treatment agent for thermoplastic synthetic fiber
GB8813012D0 (en) 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
SG43007A1 (en) * 1989-09-11 1997-10-17 Kao Corp Bleaching composition
NO952796D0 (no) 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
JP4349744B2 (ja) 1997-08-29 2009-10-21 ザ・ジョーンズ・ホプキンス・ユニバーシティ 抗菌化合物
JP2000169443A (ja) 1998-10-02 2000-06-20 Sankyo Co Ltd ジチオ―ル誘導体
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850969B1 (fr) 2003-02-12 2005-03-25 Genfit S A Aminopropanediols acyles et analogues et leurs utilisations therapeutiques
FR2850870B1 (fr) 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2850869B1 (fr) 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме

Also Published As

Publication number Publication date
ES2292824T3 (es) 2008-03-16
JP2004537595A (ja) 2004-12-16
DE60222596D1 (de) 2007-10-31
EP1673338A1 (fr) 2006-06-28
DE60222596T2 (de) 2008-07-24
US20040192908A1 (en) 2004-09-30
US7375135B2 (en) 2008-05-20
EP1673338B1 (fr) 2007-09-19
DK1673338T3 (da) 2008-01-14
ATE373638T1 (de) 2007-10-15
PT1673338E (pt) 2007-12-12
CY1107806T1 (el) 2013-06-19
CA2456288A1 (fr) 2003-02-20
WO2003014073A1 (fr) 2003-02-20
AU2002342968B2 (en) 2008-05-15
FR2828487A1 (fr) 2003-02-14

Similar Documents

Publication Publication Date Title
FR2828487B1 (fr) Nouveaux composes derives d'acides gras, preparation et utilisations
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
DE60231555D1 (de) Verbesserte synthese von polyanhydriden
ATE328965T1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
AR013608A1 (es) Derivados de 3,4-diariloxazolona, procedimiento para su preparacion, y composicion farmaceutica que los comprende.
YU5199A (sh) Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija
ATE540934T1 (de) Verfahren zur herstellung substituierter anilinverbindungen
DE69938153D1 (de) Verfahren zur herstellung von alkylmercaptomethylergolinderivaten
ATE229000T1 (de) Verfahren zur herstellung von alpha-aminoketonen
PT1205476E (pt) Processo de sintese de derivados n-(mercapto-acil)-aminoacidos a partir de acidos acrilicos alfa-substituidos
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
ATE82861T1 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
GR910100202A (el) Μέθοδος δια την παρασκευή 2,2-διμεθυλ-5(2,5 διμεθυλοφαινοξυ)-πεντανοϊκού οξέος, ενδιάμεσων ουσιών και μέθοδος δια την παρασκευή των ενδιάμεσων ουσιών.
DK0643055T3 (da) Fremgangsmåde til fremstilling af 5-amino-2,2-dialkyl-1,3-dioxaner
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE69410073D1 (de) Verfahren zur Herstellung von 2-Perfluoroalkyl-3-oxazolin-5-one
FR2793246B1 (fr) Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE434611T1 (de) Verfahren zur herstellung von estern der amicsäure
DE69619402D1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
KR920009818A (ko) 신규 벤조디옥솔 유도체 및 이를 함유하는 간장해 개선제
DE3580587D1 (de) Ester der 0(2,6-dichlorphenylamino)phenylessigsaeure und ein verfahren zur deren herstellung.
DE69618096D1 (de) Neue carbonsäure-derivate, verfahren zur herstellung und diese verbindungen enthaltende insektizide
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
ATE229500T1 (de) Verfahren zur herstellung von trion- bis(oximether) derivaten sowie damit erhältliche trion-mono- und trion-bis(oximether) derivate

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100430